Samlyn Capital, LLC Biogen Inc. Call Options Transaction History

Samlyn Capital, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $21.5 Million - $32.4 Million	-91,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $24.1 Million - $27.8 Million	91,000 New	91,000 $25.8 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $129 Million - $142 Million	-587,900 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $127 Million - $199 Million	587,900 New	587,900 $139 Million

1,015

126M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.